Editorial: Advance in translational genomics based biomarkers for cancer management: discovery and application

Guodong Zhao; Qinyu Ge; Wenjun Lan; Bo Zheng; Yuting Liang

doi:10.3389/fgene.2023.1342616

Editorial: Advance in translational genomics based biomarkers for cancer management: discovery and application

Front Genet. 2023 Dec 12:14:1342616. doi: 10.3389/fgene.2023.1342616. eCollection 2023.

Authors

Guodong Zhao¹, Qinyu Ge², Wenjun Lan³, Bo Zheng⁴, Yuting Liang⁵

Affiliations

¹ Zhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, Jiangsu, China.
² State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
³ Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
⁴ The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
⁵ Center for Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

No abstract available

Keywords: biomarkers; cancer management; challenges; discovery; translational genomics.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Kunshan Association for Science and Technology Youth Science and Technology Talent Promotion Project.